首页> 外国专利> AUTOMATED TUMOUR-STROMA INTERFACE ZONE DETECTION FOR ANTI-TUMOUR RESPONSE ASSESSMENT BY IMMUNOGRADIENT INDICATORS

AUTOMATED TUMOUR-STROMA INTERFACE ZONE DETECTION FOR ANTI-TUMOUR RESPONSE ASSESSMENT BY IMMUNOGRADIENT INDICATORS

机译:免疫指标自动评估抗肿瘤反应区域

摘要

The present invention provides new method for automatically determining the tumour/stroma interface zone (IZ) from microscopy image analysis data. First of all delineates the tumour edge using a set of explicit rules in grid-subsampled tissue areas; then the IZ of controlled width is sampled and ranked by the distance from the tumour edge to compute TIL density profiles across the IZ. From this data, a set of novel Immunogradient indicators are computed to reflect TIL “gravitation” towards the tumour. We applied the method on CD8 immunohistochemistry images of surgically excised breast and colorectal cancers to predict overall patient survival. In both patient cohorts, we found strong and independent prognostic value of the Immunogradient indicators, outperforming methods currently available. We conclude that data-driven, automated, human operator-independent IZ sampling enables precise spatial immune response measurement in the tumour-host interaction frontline for prediction of disease and therapy outcomes.
机译:本发明提供了用于从显微镜图像分析数据自动确定肿瘤/基质界面区(IZ)的新方法。首先,在网格下采样的组织区域中使用一组明确的规则来描绘肿瘤边缘;然后对宽度受控的IZ进行采样,并按距肿瘤边缘的距离进行排序,以计算IZ上的TIL密度分布。根据这些数据,计算出一组新颖的免疫梯度指标,以反映TIL对肿瘤的“引力”。我们在手术切除的乳腺癌和结直肠癌的CD8免疫组织化学图像上应用了该方法,以预测患者的总体生存率。在这两个患者队列中,我们发现免疫梯度指标的强大且独立的预后价值,优于目前可用的方法。我们得出的结论是,数据驱动,自动化,独立于操作人员的IZ采样可在肿瘤与宿主相互作用的前沿进行精确的空间免疫反应测量,以预测疾病和治疗结果。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号